SEC Form 4 · accession 0001209191-18-029247
AERIE PHARMACEUTICALS INC · AERI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard J Rubino
Officer — Chief Financial Officer
Period of report
Feb 23, 2018
Accepted (ET)
May 10, 2018 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 23, 2018 | F | 410 | $53.85 | D | 419,883 | D | |
| Common Stock | Feb 24, 2018 | F | 857 | $53.85 | D | 419,026 | D | |
| Common Stock | Feb 25, 2018 | F | 776 | $53.85 | D | 418,250 | D |
Table II — derivative securities
No Table II lines on this filing.